These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 15829997)

  • 1. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
    Curgunlu A; Uzun H; Bavunoğlu I; Karter Y; Genç H; Vehid S
    J Hum Hypertens; 2005 Aug; 19(8):629-33. PubMed ID: 15829997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium and angiogenesis in white coat hypertension.
    Karter Y; Aydin S; Curgunlu A; Uzun H; Ertürk N; Vehid S; Kutlu A; Simsek G; Yücel R; Arat A; Ozturk E; Erdine S
    J Hum Hypertens; 2004 Nov; 18(11):809-14. PubMed ID: 15215878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia: an additional risk factor in white coat hypertension.
    Curgunlu A; Karter Y; Uzun H; Aydin S; Ertürk N; Vehid S; Simsek G; Kutlu A; Oztürk E; Erdine S
    Int Heart J; 2005 Mar; 46(2):245-54. PubMed ID: 15876808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent?
    Karter Y; Curgunlu A; Altinişik S; Ertürk N; Vehid S; Mihmanli I; Ayan F; Kutlu A; Arat A; Oztürk E; Erdine S
    Blood Press; 2003; 12(5-6):307-13. PubMed ID: 14763662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and nitric oxide level in patients with white coat hypertension.
    Guven A; Tolun F; Caliskan M; Ciftci O; Muderrisoglu H
    Blood Press; 2012 Oct; 21(5):281-5. PubMed ID: 22229480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.
    Perticone F; Sciacqua A; Maio R; Perticone M; Maas R; Boger RH; Tripepi G; Sesti G; Zoccali C
    J Am Coll Cardiol; 2005 Aug; 46(3):518-23. PubMed ID: 16053968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus.
    Taner A; Unlu A; Kayrak M; Tekinalp M; Ayhan SS; Arıbaş A; Erdem SS
    Atherosclerosis; 2013 Jun; 228(2):432-7. PubMed ID: 23540293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
    Goonasekera CD; Rees DD; Woolard P; Frend A; Shah V; Dillon MJ
    J Hypertens; 1997 Aug; 15(8):901-9. PubMed ID: 9280214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma.
    Vasilev V; Matrozova J; Elenkova A; Vandeva S; Kirilov G; Zacharieva S
    Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):551-5. PubMed ID: 24002898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
    Jepson RE; Syme HM; Vallance C; Elliott J
    J Vet Intern Med; 2008; 22(2):317-24. PubMed ID: 18371026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension.
    Skoro-Sajer N; Mittermayer F; Panzenboeck A; Bonderman D; Sadushi R; Hitsch R; Jakowitsch J; Klepetko W; Kneussl MP; Wolzt M; Lang IM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1154-60. PubMed ID: 17872491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1.
    Yavuzer S; Yavuzer H; Cengiz M; Erman H; Altıparmak MR; Korkmazer B; Balci H; Simsek G; Yaldıran AL; Karter Y; Uzun H
    J Hum Hypertens; 2015 Feb; 29(2):92-8. PubMed ID: 25007999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine and hemodynamic regulation in middle-aged men.
    Päivä H; Laakso J; Kähönen M; Turjanmaa V; Kööbi T; Majahalme S; Lehtimäki T; Ruokonen I; Laaksonen R
    Metabolism; 2006 Jun; 55(6):771-7. PubMed ID: 16713437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients].
    Wu CJ; Wang L; Li X; Wang CX; Ma JP; Xia XS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):1003-8. PubMed ID: 23363713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
    Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in white coat hypertension; role of paraoxonase.
    Uzun H; Karter Y; Aydin S; Curgunlu A; Simşek G; Yücel R; Vehiyd S; Ertürk N; Kutlu A; Benian A; Yaldiran A; Oztürk E; Erdine S
    J Hum Hypertens; 2004 Jul; 18(7):523-8. PubMed ID: 14985779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay.
    Schulze F; Wesemann R; Schwedhelm E; Sydow K; Albsmeier J; Cooke JP; Böger RH
    Clin Chem Lab Med; 2004; 42(12):1377-83. PubMed ID: 15576299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.